← Leaderboards
Julien Fey
Novasterilis, Inc.
$1,996,031
Attributed
$1,996,031
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $667.8K · FY2013–18$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,996,031 · 5
By mechanism
R44$1,557,639 · 2
R43$288,392 · 2
R41$150,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyBasePathogenSurfacePropertyCarbon DioxideMedical DeviceMicrobicidePressureSterilizationTissuesSterilityPeracetic AcidDevicesAllograftingMaintenanceBacteriaIn VivoKillingsIndustryAreaImmunogenicInnovationLeft
Grant awards (6)
Optimization of Supercritical Carbon Dioxide Based Virus Inactivation, Characterized by Protein Damage and Maintenance of Epitope Integrity in Vaccine Sterilization$431,739
R44 · FY2018 · AI · contact PI
Optimization of Supercritical Carbon Dioxide Based Virus Inactivation, Characterized by Protein Damage and Maintenance of Epitope Integrity in Vaccine Sterilization$608,082
R44 · FY2017 · AI · contact PI
Sporocidal Mechanism and Inline Monitoring of Peracetic Acid in Supercritical CO2$147,340
R43 · FY2015 · AI · contact PI
Optimization of Supercritical Carbon Dioxide Based Virus Inactivation, Characterized by Protein Damage and Maintenance of Epitope Integrity in Vaccine Sterilization$141,052
R43 · FY2015 · AI · contact PI
Feasibility of Supercritical Carbon Dioxide Sterilization for Absorbable Suture M$517,818
R44 · FY2013 · GM · contact PI
Screens for Novel Agonists/Antagonists of Endocrine Fibroblast Growth Factors$150,000
R41 · FY2013 · DK · contact PI